Want to keep cancer patients and providers safe during the pandemic? Here’s howApril 20, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
Oncologists need to advocate for scarce COVID-19 resources: ASCOApril 15, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
ASCO announces its own COVID-19 and cancer registryApril 13, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
Cancer prevalence among COVID-19 patients may be higher than previously reportedApril 13, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
Managing pediatric heme/onc departments during the pandemicApril 9, 2020PediatricsLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
Conducting cancer trials amid the COVID-19 pandemicApril 8, 2020PediatricsLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
‘Brutal’ plan to restrict palliative radiation during pandemicApril 6, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
Maintaining cancer care in the face of COVID-19April 1, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPediatrics
Despite strict controls, some infants born to mothers with COVID-19 appear infectedMarch 27, 2020Pediatrics
Late effects in young cancer survivors underscore importance of high-risk screeningFebruary 21, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
Promising early efficacy of venetoclax/navitoclax in r/r acute lymphoblastic leukemiaJanuary 15, 2020ALLLeukemia, Myelodysplasia, TransplantationPediatrics
NCCN guidelines highlight ‘complicated’ treatment for pediatric lymphomasJanuary 14, 2020Aggressive LymphomasPediatricsDLBCLLymphoma & Plasma Cell Disorders
